Prostate Cancer Highlights

WASHINGTON, DC USA (UroToday.com) - Despite historical concerns regarding testosterone replacement therapy (TRT) in any men with a history of prostate cancer, there is increasing awareness that it is safe in selected patients.

Read more...

WASHINGTON, DC USA (UroToday.com) - This group looked at the long-term follow up (greater than 1 year) of over 300 patients who underwent robotic radical prostatectomy in which a suprapubic catheter was used for urinary drainage.

Read more...

WASHINGTON, DC USA (UroToday.com) - Denosumab interrupts the reciprocal interaction of tumor and bone cells.

Read more...

WASHINGTON, DC USA (UroToday.com) - Dr. Kathleen Cooney discussed the analysis of families with high incidences of prostate cancer (CaP) that led to genetic analyses.

Read more...

WASHINGTON, DC USA (UroToday.com) - There are two types of risk, those of missing findings and those resulting from imaging.

Read more...

WASHINGTON, DC USA (UroToday.com) -The research group evaluated the effect of long-acting testosterone injection for treatment of hypogonadism after brachytherapy for prostate cancer.

Read more...

WASHINGTON, DC USA (UroToday.com) - Authors noted a 1% infection rate in first line IPP placement and a 3.8% in revisions.

Read more...

WASHINGTON, DC USA (UroToday.com) - A publication with 10 years follow-up is pending, but currently the data is embargoed.

Read more...

WASHINGTON, DC USA (UroToday.com) - Dr. Timothy Wilt provided an update on the PIVOT trial; Prostate Cancer Intervention vs. Observation Trial.

Read more...

WASHINGTON, DC USA (UroToday.com) - 5-alpha reductase inhibitors (5ARIs) are associated with a significantly lower rate of pathologic progression and abandonment of active surveillance, Dr. Antonio Finelli reported.

Read more...